Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 20/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4791654 | 0.90 | CXCR4 (0.63) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL3265558 | 0.88 | CXCR4 (0.69) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL2510467 | 0.81 | CXCR4 (0.77) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL3267285 | 0.81 | CXCR4 (0.72) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL2509900 | 0.80 | CXCR4 (0.73) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL2506336 | 0.80 | CXCR4 (0.66) | CXCR4 | |
| SCHEMBL2507422 | 0.80 | CXCR4 (0.68) | CXCR4 | |
| SCHEMBL2508375 | 0.79 | CXCR4 (0.77) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL2504776 | 0.78 | CXCR4 (0.86) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL2507346 | 0.78 | CXCR4 (0.83) | CXCR4CHRM2CYP2D6DRD2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1991221-A2 | METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION | Genzyme Corporation (US) | 2008-11-19 | — | — | EP | disclosed |
| WO-2007106063-A2 | METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION | GENZYME CORPORATION (US) | 2007-09-20 | — | — | WO | disclosed |